Candida lusitaniae: Biology, Pathogenicity, Virulence Factors, Diagnosis, and Treatment

References

• Aguiar Cordeiro R, de Jesus Evangelista AJ, Serpa R, et al. β-lactam antibiotics & vancomycin increase the growth & virulence of Candida spp. Future Microbiol. 2018;13(8):869–875. doi:10.2217/fmb-2018-0019
   Web of Science ®Google Scholar
• Goncalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905–927. doi:10.3109/1040841X.2015.1091805
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Mendez M, et al. Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. J Clin Microbiol. 2006;44(10):3551–3556. doi:10.1128/JCM.00865-06
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis. 1998;30(2):121–129. doi:10.1016/S0732-8893(97)00192-2
   PubMed Web of Science ®Google Scholar
• Pfaller M, Neofytos D, Diekema D, et al. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008. Diagn Microbiol Infect Dis. 2012;74(4):323–331. doi:10.1016/j.diagmicrobio.2012.10.003
   PubMed Web of Science ®Google Scholar
• Andes DR, Safdar N, Baddley JW, et al. The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Transpl Infect Dis. 2016;18(6):921–931. doi:10.1111/tid.12613
   Web of Science ®Google Scholar
• Minari A, Hachem R, Raad I. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. Clin Infect Dis. 2001;32(2):186–190. doi:10.1086/318473
   PubMed Web of Science ®Google Scholar
• Fakhim H, Vaezi A, Dannaoui E, et al. Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model. Mycoses. 2018;61(6):377–382. doi:10.1111/myc.12754
   PubMed Web of Science ®Google Scholar
• Fakhim H, Vaezi A, Javidnia J, et al. Candida africana vulvovaginitis: prevalence and geographical distribution. J Mycol Med. 2020;30(3):100966. doi:10.1016/j.mycmed.2020.100966
   PubMed Web of Science ®Google Scholar
• Hawkins JL, Baddour LM. Candida lusitaniae infections in the era of fluconazole availability. Clin Infect Dis. 2003;36(2):e14–18. doi:10.1086/344651
   PubMed Web of Science ®Google Scholar
• Baker JG, Nadler HL, Forgacs P, Kurtz SR. Candida lusitaniae: a new opportunistic pathogen of the urinary tract. Diagn Microbiol Infect Dis. 1984;2(2):145–149. doi:10.1016/0732-8893(84)90010-5
   Web of Science ®Google Scholar
• Sanchez V, Vazquez JA, Barth-Jones D, Dembry L, Sobel JD, Zervos MJ. Epidemiology of nosocomial acquisition of Candida lusitaniae. J Clin Microbiol. 1992;30(11):3005–3008. doi:10.1128/jcm.30.11.3005-3008.1992
   PubMed Web of Science ®Google Scholar
• Zhang H, Ran Y, Li D, et al. Clavispora lusitaniae and Chaetomium atrobrunneum as rare agents of cutaneous infection. Mycopathologia. 2010;169(5):373–380. doi:10.1007/s11046-009-9266-9
   Web of Science ®Google Scholar
• Jung DS, Farmakiotis D, Jiang Y, Tarrand JJ, Kontoyiannis DP. Uncommon Candida species fungemia among cancer patients, Houston, Texas, USA. Emerg Infect Dis. 2015;21(11):1942–1950. doi:10.3201/eid2111.150404
   PubMed Web of Science ®Google Scholar
• Obisesan OJ, Olowe OA, Taiwo SS. Phenotypic detection of genitourinary candidiasis among sexually transmitted disease clinic attendees in Ladoke Akintola University Teaching Hospital, Osogbo, Nigeria. J Environ Public Health. 2015;2015:401340. doi:10.1155/2015/401340
   Google Scholar
• Hadfield TL, Smith MB, Winn RE, Rinaldi MG, Guerra C. Mycoses caused by Candida lusitaniae. Rev Infect Dis. 1987;9(5):1006–1012. doi:10.1093/clinids/9.5.1006
   Google Scholar
• Boisnard S, Ruprich-Robert G, Florent M, Da Silva B, Chapeland-Leclerc F, Papon N. Role of Sho1p adaptor in the pseudohyphal development, drugs sensitivity, osmotolerance and oxidant stress adaptation in the opportunistic yeast Candida lusitaniae. Yeast. 2008;25(11):849–859. doi:10.1002/yea.1636
   Web of Science ®Google Scholar
• Zhang J, Silao FG, Bigol UG, et al. Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae. PLoS One. 2012;7(8):e44192. doi:10.1371/journal.pone.0044192
   Web of Science ®Google Scholar
• McClenny NB, Fei H, Baron EJ, et al. Change in colony morphology of Candida lusitaniae in association with development of amphotericin B resistance. Antimicrob Agents Chemother. 2002;46(5):1325–1328. doi:10.1128/AAC.46.5.1325-1328.2002
   Web of Science ®Google Scholar
• Yoon SA, Vazquez JA, Steffan PE, Sobel JD, Akins RA. High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance. Antimicrob Agents Chemother. 1999;43(4):836–845. doi:10.1128/AAC.43.4.836
   PubMed Web of Science ®Google Scholar
• Reedy JL, Floyd AM, Heitman J. Mechanistic plasticity of sexual reproduction and meiosis in the Candida pathogenic species complex. Curr Biol. 2009;19(11):891–899. doi:10.1016/j.cub.2009.04.058
   PubMed Web of Science ®Google Scholar
• Gargeya IB, Pruitt WR, Simmons RB, Meyer SA, Ahearn DG. Occurrence of Clavispora lusitaniae, the teleomorph of Candida lusitaniae, among clinical isolates. J Clin Microbiol. 1990;28(10):2224–2227. doi:10.1128/jcm.28.10.2224-2227.1990
   Web of Science ®Google Scholar
• Francois F, Noel T, Pepin R, et al. Alternative identification test relying upon sexual reproductive abilities of Candida lusitaniae strains isolated from hospitalized patients. J Clin Microbiol. 2001;39(11):3906–3914. doi:10.1128/JCM.39.11.3906-3914.2001
   Web of Science ®Google Scholar
• Young LY, Lorenz MC, Heitman J. A STE12 homolog is required for mating but dispensable for filamentation in Candida lusitaniae. Gene. 2000;155(1):17–29.
   Google Scholar
• Leite de Andrade MC, Soares de Oliveira MA, Santos F, et al. A new approach by optical coherence tomography for elucidating biofilm formation by emergent Candida species. PLoS One. 2017;12(11):e0188020. doi:10.1371/journal.pone.0188020
   Web of Science ®Google Scholar
• Diaz-Jimenez DF, Mora-Montes HM, Hernandez-Cervantes A, Luna-Arias JP, Gow NA, Flores-Carreon A. Biochemical characterization of recombinant Candida albicans mannosyltransferases Mnt1, Mnt2 and Mnt5 reveals new functions in O- and N-mannan biosynthesis. Biochem Biophys Res Commun. 2012;419(1):77–82. doi:10.1016/j.bbrc.2012.01.131
   Web of Science ®Google Scholar
• Gomez-Gaviria M, Mora-Montes HM. Current aspects in the biology, pathogeny, and treatment of Candida krusei, a neglected fungal pathogen. Infect Drug Resist. 2020;13:1673–1689. doi:10.2147/IDR.S247944
   PubMed Web of Science ®Google Scholar
• Mora-Montes HM, Ponce-Noyola P, Villagomez-Castro JC, Gow NA, Flores-Carreon A, Lopez-Romero E. Protein glycosylation in Candida. Future Microbiol. 2009;4(9):1167–1183. doi:10.2217/fmb.09.88
   PubMed Web of Science ®Google Scholar
• Estrada-Mata E, Navarro-Arias MJ, Perez-Garcia LA, et al. Members of the Candida parapsilosis complex and Candida albicans are differentially recognized by human peripheral blood mononuclear cells. Front Microbiol. 2015;6:1527. doi:10.3389/fmicb.2015.01527
   PubMed Web of Science ®Google Scholar
• Gómez-Gaviria M, García-Carnero LC, Tamez-Castrellón AK, Mora-Montes HM. The cell wall of medically relevant yeasts and molds. In: Zaragoza Ó, Casadevall A, editors. Encyclopedia of Mycology. Oxford: Elsevier; 2021:12–22.
   Google Scholar
• Hernandez-Chavez MJ, Clavijo-Giraldo DM, Novak A, et al. Role of protein mannosylation in the Candida tropicalis-host interaction. Front Microbiol. 2019;10:2743. doi:10.3389/fmicb.2019.02743
   PubMed Web of Science ®Google Scholar
• Hernandez-Chavez MJ, Franco B, Clavijo-Giraldo DM, Hernandez NV, Estrada-Mata E, Mora-Montes HM. Role of protein phosphomannosylation in the Candida tropicalis-macrophage interaction. FEMS Yeast Res. 2018;18(5). doi:10.1093/femsyr/foy053
   Web of Science ®Google Scholar
• Navarro-Arias MJ, Hernandez-Chavez MJ, Garcia-Carnero LC, et al. Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells. Infect Drug Resist. 2019;12:783–794. doi:10.2147/IDR.S197531
   PubMed Web of Science ®Google Scholar
• Perez-Garcia LA, Csonka K, Flores-Carreon A, et al. Role of protein glycosylation in Candida parapsilosis cell wall integrity and host interaction. Front Microbiol. 2016;7:306. doi:10.3389/fmicb.2016.00306
   PubMed Web of Science ®Google Scholar
• Toth R, Nosek J, Mora-Montes HM, et al. Candida parapsilosis: from genes to the bedside. Clin Microbiol Rev. 2019;32(2). doi:10.1128/CMR.00111-18
   PubMed Web of Science ®Google Scholar
• Joshi KR, Wheeler EE, Gavin JB. The ultrastructure of Candida krusei. Mycopathologia. 1975;56(1):5–8. doi:10.1007/BF00493575
   Web of Science ®Google Scholar
• Grigor’eva A, Bardasheva A, Tupitsyna A, et al. Changes in the ultrastructure of Candida albicans treated with cationic peptides. Microorganisms. 2020;8(4):582.
   Web of Science ®Google Scholar
• Gómez-Gaviria M, Vargas-Macías AP, García-Carnero LC, Martínez-Duncker I, Mora-Montes HM. Role of protein glycosylation in interactions of medically relevant fungi with the host. J Fungi. 2021;7(10):875. doi:10.3390/jof7100875
   Web of Science ®Google Scholar
• Navarro-Arias MJ, Defosse TA, Dementhon K, et al. Disruption of protein mannosylation affects Candida guilliermondii cell wall, immune sensing, and virulence. Front Microbiol. 2016;7:1951. doi:10.3389/fmicb.2016.01951
   PubMed Web of Science ®Google Scholar
• Navarro-Arias MJ, Dementhon K, Defosse TA, et al. Group X hybrid histidine kinase Chk1 is dispensable for stress adaptation, host-pathogen interactions and virulence in the opportunistic yeast Candida guilliermondii. Res Microbiol. 2017;168(7):644–654. doi:10.1016/j.resmic.2017.04.009
   Web of Science ®Google Scholar
• Hernandez-Chavez MJ, Perez-Garcia LA, Nino-Vega GA, Mora-Montes HM. Fungal strategies to evade the host immune recognition. J Fungi. 2017;3(4):51. doi:10.3390/jof3040051
   Web of Science ®Google Scholar
• Gow NA, Netea MG, Munro CA, et al. Immune recognition of Candida albicans beta-glucan by dectin-1. J Infect Dis. 2007;196(10):1565–1571. doi:10.1086/523110
   PubMed Web of Science ®Google Scholar
• Mora-Montes HM, Netea MG, Ferwerda G, et al. Recognition and blocking of innate immunity cells by Candida albicans chitin. Infect Immun. 2011;79(5):1961–1970. doi:10.1128/IAI.01282-10
   Web of Science ®Google Scholar
• Walker LA, Munro CA. Caspofungin induced cell wall changes of Candida species influences macrophage interactions. Front Cell Infect Microbiol. 2020;10:164. doi:10.3389/fcimb.2020.00164
   PubMed Web of Science ®Google Scholar
• Shibata N, Kobayashi H, Suzuki S. Immunochemistry of pathogenic yeast, Candida species, focusing on mannan. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(6):250–265. doi:10.2183/pjab.88.250
   PubMed Web of Science ®Google Scholar
• Klis FM, de Groot P, Hellingwerf K. Molecular organization of the cell wall of Candida albicans. Med Mycol. 2001;39(Suppl 1):1–8. doi:10.1080/mmy.39.1.1.8-0
   PubMed Web of Science ®Google Scholar
• Mora-Montes HM, Bates S, Netea MG, et al. A multifunctional mannosyltransferase family in Candida albicans determines cell wall mannan structure and host-fungus interactions. J Biol Chem. 2010;285(16):12087–12095. doi:10.1074/jbc.M109.081513
   PubMed Web of Science ®Google Scholar
• Mukaremera L, Lee KK, Mora-Montes HM, Gow NAR. Candida albicans yeast, pseudohyphal, and hyphal morphogenesis differentially affects immune recognition. Front Immunol. 2017;8:629. doi:10.3389/fimmu.2017.00629
   PubMed Web of Science ®Google Scholar
• Munro CA, Bates S, Buurman ET, et al. Mnt1p and Mnt2p of Candida albicans are partially redundant alpha-1,2-mannosyltransferases that participate in O-linked mannosylation and are required for adhesion and virulence. J Biol Chem. 2005;280(2):1051–1060. doi:10.1074/jbc.M411413200
   Web of Science ®Google Scholar
• Shibata N, Kobayashi H, Okawa Y, Suzuki S. Existence of novel beta-1,2 linkage-containing side chain in the mannan of Candida lusitaniae, antigenically related to Candida albicans serotype A. Eur J Biochem. 2003;270(12):2565–2575. doi:10.1046/j.1432-1033.2003.03622.x
   Google Scholar
• Gow NAR, Latge JP, Munro CA. The fungal cell wall: structure, biosynthesis, and function. Microbiol spect. 2017;5(3). doi:10.1128/microbiolspec.FUNK-0035-2016
   Web of Science ®Google Scholar
• Díaz-Jiménez DF, Pérez-García LA, Martínez-álvarez JA, Mora-Montes HM. Role of the fungal cell wall in pathogenesis and antifungal resistance. Curr Fungal Infect Rep. 2012;6(4):275–282. doi:10.1007/s12281-012-0109-7
   Google Scholar
• Gow NA, van de Veerdonk FL, Brown AJ, Netea MG. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol. 2012;10(2):112–122. doi:10.1038/nrmicro2711
   Web of Science ®Google Scholar
• Freer SN. Fermentation and aerobic metabolism of cellodextrins by yeasts. Appl Environ Microbiol. 1991;57(3):655–659. doi:10.1128/aem.57.3.655-659.1991
   Web of Science ®Google Scholar
• Lachance M-A. Chapter 21 - Clavispora Rodrigues de Miranda (1979). In: Kurtzman CP, Fell JW, Boekhout T, editors. The Yeasts. 5th ed. London: Elsevier; 2011:349–353.
   Google Scholar
• Ene IV, Adya AK, Wehmeier S, et al. Host carbon sources modulate cell wall architecture, drug resistance and virulence in a fungal pathogen. Cell Microbiol. 2012;14(9):1319–1335. doi:10.1111/j.1462-5822.2012.01813.x
   PubMed Web of Science ®Google Scholar
• Priest SJ, Lorenz MC. Characterization of virulence-related phenotypes in Candida species of the CUG clade. Eukaryot Cell. 2015;14(9):931–940. doi:10.1128/EC.00062-15
   Google Scholar
• Sherwood RK, Scaduto CM, Torres SE, Bennett RJ. Convergent evolution of a fused sexual cycle promotes the haploid lifestyle. Nature. 2014;506(7488):387–390. doi:10.1038/nature12891
   Web of Science ®Google Scholar
• Butler G, Rasmussen MD, Lin MF, et al. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature. 2009;459(7247):657–662. doi:10.1038/nature08064
   PubMed Web of Science ®Google Scholar
• Kannan A, Asner SA, Trachsel E, Kelly S, Parker J, Sanglard D. Comparative genomics for the elucidation of multidrug resistance in Candida lusitaniae. mBio. 2019;10(6):e02512–02519. doi:10.1128/mBio.02512-19
   Web of Science ®Google Scholar
• de Groot PWJ, Bader O, de Boer AD, Weig M, Chauhan N. Adhesins in human fungal pathogens: glue with plenty of stick. Eukaryot Cell. 2013;12(4):470–481. doi:10.1128/EC.00364-12
   PubMed Web of Science ®Google Scholar
• Willaert RG. Adhesins of yeasts: protein structure and interactions. J Fungi. 2018;4(4):119. doi:10.3390/jof4040119
   Web of Science ®Google Scholar
• Biasoli MS, Tosello ME, Magaró HM. Adherence of Candida strains isolated from the human gastrointestinal tract. Mycoses. 2002;45(11–12):465–469. doi:10.1046/j.1439-0507.2002.00793.x
   Web of Science ®Google Scholar
• de Repentigny L, Aumont F, Bernard K, Belhumeur P. Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells. Infect Immun. 2000;68(6):3172–3179. doi:10.1128/IAI.68.6.3172-3179.2000
   PubMed Web of Science ®Google Scholar
• Dorko E, Kmet’ová M, Marossy A, Dorko F, Molokácová M. Non-albicans Candida species isolated from plastic devices. Mycopathologia. 1999;148(3):117–122. doi:10.1023/A:1007178806720
   Web of Science ®Google Scholar
• Staniszewska M. Virulence factors in Candida species. Curr Protein Pept Sci. 2020;21(3):313–323. doi:10.2174/1389203720666190722152415
   Web of Science ®Google Scholar
• Nordin MA, Wan Harun WH, Abdul Razak F. An in vitro study on the anti-adherence effect of Brucea javanica and Piper betle extracts towards oral Candida. Arch Oral Biol. 2013;58(10):1335–1342. doi:10.1016/j.archoralbio.2013.07.001
   PubMed Web of Science ®Google Scholar
• Muadcheingka T, Tantivitayakul P. Distribution of Candida albicans and non-albicans Candida species in oral candidiasis patients: correlation between cell surface hydrophobicity and biofilm forming activities. Arch Oral Biol. 2015;60(6):894–901. doi:10.1016/j.archoralbio.2015.03.002
   Web of Science ®Google Scholar
• Panagoda GJ, Ellepola AN, Samaranayake LP. Adhesion to denture acrylic surfaces and relative cell-surface hydrophobicity of Candida parapsilosis and Candida albicans. APMIS. 1998;106(7):736–742. doi:10.1111/j.1699-0463.1998.tb00220.x
   Web of Science ®Google Scholar
• Bujdáková H, Didiášová M, Drahovská H, Černáková L. Role of cell surface hydrophobicity in Candida albicans biofilm. Open Life Sci. 2013;8(3):259–262. doi:10.2478/s11535-013-0136-y
   Web of Science ®Google Scholar
• Krasowska A, Sigler K. How microorganisms use hydrophobicity and what does this mean for human needs? Front Cell Infect Microbiol. 2014;4:112. doi:10.3389/fcimb.2014.00112
   PubMed Web of Science ®Google Scholar
• Blanco MT, Morales JJ, Lucio L, Pérez-Giraldo C, Hurtado C, Gómez-García AC. Modification of adherence to plastic and to human buccal cells of Candida albicans and Candida dubliniensis by a subinhibitory concentration of itraconazole. Oral Microbiol Immunol. 2006;21(1):69–72. doi:10.1111/j.1399-302X.2005.00260.x
   Google Scholar
• Gulati M, Nobile CJ. Candida albicans biofilms: development, regulation, and molecular mechanisms. Microbes Infect. 2016;18(5):310–321. doi:10.1016/j.micinf.2016.01.002
   PubMed Web of Science ®Google Scholar
• Pathirana RU, McCall AD, Norris HL, Edgerton M. Filamentous non-albicans Candida species adhere to Candida albicans and benefit from dual biofilm growth. Front Microbiol. 2019;10:1188. doi:10.3389/fmicb.2019.01188
   PubMed Web of Science ®Google Scholar
• Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses. 2005;48(6):365–377. doi:10.1111/j.1439-0507.2005.01165.x
   PubMed Web of Science ®Google Scholar
• Pichová I, Pavlícková L, Dostál J, et al. Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors. Eur J Biochem. 2001;268(9):2669–2677. doi:10.1046/j.1432-1327.2001.02152.x
   Google Scholar
• Braun BR, Johnson AD. TUP1, CPH1 and EFG1 make independent contributions to filamentation in Candida albicans. Genetics. 2000;155(1):57–67. doi:10.1093/genetics/155.1.57
   PubMed Web of Science ®Google Scholar
• Cleary IA, Lazzell AL, Monteagudo C, Thomas DP, Saville SP. BRG1 and NRG1 form a novel feedback circuit regulating Candida albicans hypha formation and virulence. Mol Microbiol. 2012;85(3):557–573. doi:10.1111/j.1365-2958.2012.08127.x
   PubMed Web of Science ®Google Scholar
• Zheng X, Wang Y, Wang Y. Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J. 2004;23(8):1845–1856. doi:10.1038/sj.emboj.7600195
   PubMed Web of Science ®Google Scholar
• Miller NS, Dick JD, Merz WG. Phenotypic switching in Candida lusitaniae on copper sulfate indicator agar: association with amphotericin B resistance and filamentation. J Clin Microbiol. 2006;44(4):1536–1539. doi:10.1128/JCM.44.4.1536-1539.2006
   Web of Science ®Google Scholar
• Sanchez Y, Lindquist SL. HSP104 required for induced thermotolerance. Science. 1990;248(4959):1112–1115. doi:10.1126/science.2188365
   Web of Science ®Google Scholar
• Gong Y, Li T, Yu C, Sun S. Candida albicans heat shock proteins and Hsps-associated signaling pathways as potential antifungal targets. Front Cell Infect Microbiol. 2017;7(520):520. doi:10.3389/fcimb.2017.00520
   Web of Science ®Google Scholar
• Papon N, Courdavault V, Clastre M, Bennett RJ. Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm. PLoS Pathog. 2013;9(9):e1003550.
   PubMed Web of Science ®Google Scholar
• Martinez-Alvarez JA, Perez-Garcia LA, Flores-Carreon A, Mora-Montes HM. The immune response against Candida spp. and Sporothrix schenckii. Rev Iberoam Micol. 2014;31(1):62–66. doi:10.1016/j.riam.2013.09.015
   PubMed Web of Science ®Google Scholar
• Netea MG, Brown GD, Kullberg BJ, Gow NA. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol. 2008;6(1):67–78. doi:10.1038/nrmicro1815
   PubMed Web of Science ®Google Scholar
• Netea MG, Joosten LA, van der Meer JW, Kullberg BJ, van de Veerdonk FL. Immune defence against Candida fungal infections. Nat Rev Immunol. 2015;15(10):630–642. doi:10.1038/nri3897
   PubMed Web of Science ®Google Scholar
• Reid DM, Gow NAR, Brown GD. Pattern recognition: recent insights from Dectin-1. Curr Opin Immunol. 2009;21(1):30–37. doi:10.1016/j.coi.2009.01.003
   PubMed Web of Science ®Google Scholar
• Vecchiarelli A, Bistoni F, Cenci E, Perito S, Cassone A. In-vitro killing of Candida species by murine immunoeffectors and its relationship to the experimental pathogenicity. Sabouraudia. 1985;23(5):377–387. doi:10.1080/00362178585380541
   Google Scholar
• Høgåsen AK, Abrahamsen TG, Gaustad P. Various Candida and Torulopsis species differ in their ability to induce the production of C3, factor B and granulocyte-macrophage colony-stimulating factor (GM-CSF) in human monocyte cultures. J Med Microbiol. 1995;42(4):291–298. doi:10.1099/00222615-42-4-291
   Web of Science ®Google Scholar
• Aybay C, Imir T. Tumor necrosis factor (TNF) induction from monocyte/macrophages by Candida species. Immunobiology. 1996;196(4):363–374. doi:10.1016/S0171-2985(96)80059-3
   Web of Science ®Google Scholar
• Killick J, Morisse G, Sieger D, Astier AL. Complement as a regulator of adaptive immunity. Semin Immunopathol. 2018;40(1):37–48. doi:10.1007/s00281-017-0644-y
   PubMed Web of Science ®Google Scholar
• Singh DK, Tóth R, Gácser A. Mechanisms of pathogenic Candida species to Evade the host complement attack. Front Cell Infect Microbiol. 2020;10:94. doi:10.3389/fcimb.2020.00094
   PubMed Web of Science ®Google Scholar
• Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses. Cell Res. 2010;20(1):34–50. doi:10.1038/cr.2009.139
   PubMed Web of Science ®Google Scholar
• Meri T, Hartmann A, Lenk D, et al. The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect Immun. 2002;70(9):5185–5192. doi:10.1128/IAI.70.9.5185-5192.2002
   Web of Science ®Google Scholar
• Chi HW, Yang YS, Shang ST, et al. Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome. J Microbiol Immunol Infect. 2011;44(5):369–375. doi:10.1016/j.jmii.2010.08.010
   Google Scholar
• Khan Z, Ahmad S, Al-Sweih N, Khan S, Joseph L. Candida lusitaniae in Kuwait: prevalence, antifungal susceptibility and role in neonatal fungemia. PLoS One. 2019;14(3):e0213532. doi:10.1371/journal.pone.0213532
   Web of Science ®Google Scholar
• Luzzati R, Amalfitano G, Lazzarini L, et al. Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis. 2000;19(8):602–607. doi:10.1007/s100960000325
   Web of Science ®Google Scholar
• Chow JK, Golan Y, Ruthazer R, et al. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis. 2008;46(8):1206–1213. doi:10.1086/529435
   PubMed Web of Science ®Google Scholar
• Raja A, Park J. Disseminated Candida lusitaniae: nosocomial acquisition secondary to an indwelling urinary catheter. Case Rep Infect Dis. 2021;2021:6632730. doi:10.1155/2021/6632730
   Web of Science ®Google Scholar
• Simitsopoulou M, Kyrpitzi D, Velegraki A, Walsh TJ, Roilides E. Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii. Antimicrob Agents Chemother. 2014;58(8):4953–4956. doi:10.1128/AAC.03117-14
   Web of Science ®Google Scholar
• Fowler SL, Rhoton B, Springer SC, Messer SA, Hollis RJ, Pfaller MA. Evidence for person-to-person transmission of Candida lusitaniae in a neonatal intensive-care unit. Infect Control Hosp Epidemiol. 1998;19(5):343–345. doi:10.2307/30141376
   Web of Science ®Google Scholar
• Guinet R, Chanas J, Goullier A, Bonnefoy G, Ambroise-Thomas P. Fatal septicemia due to amphotericin B-resistant Candida lusitaniae. J Clin Microbiol. 1983;18(2):443–444. doi:10.1128/jcm.18.2.443-444.1983
   Web of Science ®Google Scholar
• Merz WG. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol. 1984;20(6):1194–1195. doi:10.1128/jcm.20.6.1194-1195.1984
   Web of Science ®Google Scholar
• Blinkhorn RJ, Adelstein D, Spagnuolo PJ. Emergence of a new opportunistic pathogen, Candida lusitaniae. J Clin Microbiol. 1989;27(2):236–240. doi:10.1128/jcm.27.2.236-240.1989
   Web of Science ®Google Scholar
• Desnos-Ollivier M, Moquet O, Chouaki T, Guérin AM, Dromer F. Development of echinocandin resistance in Clavispora lusitaniae during caspofungin treatment. J Clin Microbiol. 2011;49(6):2304–2306. doi:10.1128/JCM.00325-11
   PubMed Web of Science ®Google Scholar
• Parentin F, Liberali T, Perissutti P. Polymicrobial keratomycosis in a three-year-old child. Ocul Immunol Inflamm. 2006;14(2):129–131. doi:10.1080/09273940500328487
   PubMed Web of Science ®Google Scholar
• Huynh N, Chang HY, Borboli-Gerogiannis S. Ocular involvement in hospitalized patients with candidemia: analysis at a Boston tertiary care center. Ocul Immunol Inflamm. 2012;20(2):100–103. doi:10.3109/09273948.2011.646383
   PubMed Web of Science ®Google Scholar
• Apsemidou A, Füller MA, Idelevich EA, Kurzai O, Tragiannidis A, Groll AH. Candida lusitaniae breakthrough fungemia in an immuno-compromised adolescent: case report and review of the literature. J Fungi. 2020;6(4):380. doi:10.3390/jof6040380
   Web of Science ®Google Scholar
• Atkinson BJ, Lewis RE, Kontoyiannis DP. Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. Med Mycol. 2008;46(6):541–546. doi:10.1080/13693780801968571
   PubMed Web of Science ®Google Scholar
• Holzschu DL, Presley HL, Miranda M, Phaff HJ. Identification of Candida lusitaniae as an opportunistic yeast in humans. J Clin Microbiol. 1979;10(2):202–205. doi:10.1128/jcm.10.2.202-205.1979
   Web of Science ®Google Scholar
• Steinbach WJ, Roilides E, Berman D, et al. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J. 2012;31(12):1252–1257. doi:10.1097/INF.0b013e3182737427
   PubMed Web of Science ®Google Scholar
• Tragiannidis A, Fegeler W, Rellensmann G, et al. Candidaemia in a European Paediatric University Hospital: a 10-year observational study. Clin Microbiol Infect. 2012;18(2):E27–E30. doi:10.1111/j.1469-0691.2011.03720.x
   PubMed Web of Science ®Google Scholar
• Wawrysiuk S, Rechberger T, Futyma K, Miotła P. Candida lusitaniae - a case report of an intraperitoneal infection. Prz Menopauzalny. 2018;17(2):94–96. doi:10.5114/pm.2018.77310
   Google Scholar
• Baumgartner C, Freydiere AM, Gille Y. Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates. J Clin Microbiol. 1996;34(2):454–456. doi:10.1128/jcm.34.2.454-456.1996
   Web of Science ®Google Scholar
• Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol. 1994;32(8):1923–1929. doi:10.1128/jcm.32.8.1923-1929.1994
   PubMed Web of Science ®Google Scholar
• Cooke VM, Miles RJ, Price RG, Midgley G, Khamri W, Richardson AC. New chromogenic agar medium for the identification of Candida spp. Appl Environ Microbiol. 2002;68(7):3622–3627. doi:10.1128/AEM.68.7.3622-3627.2002
   Web of Science ®Google Scholar
• Deorukhkar SC, Roushani S. Identification of Candida species: conventional methods in the era of molecular diagnosis. Ann Microbiol Immunol. 2018;1(1):1002.
   Google Scholar
• Essendoubi M, Toubas D, Bouzaggou M, Pinon JM, Manfait M, Sockalingum GD. Rapid identification of Candida species by FT-IR microspectroscopy. Biochim Biophys Acta. 2005;1724(3):239–247. doi:10.1016/j.bbagen.2005.04.019
   Web of Science ®Google Scholar
• Elie CM, Lott TJ, Reiss E, Morrison CJ. Rapid identification of Candida species with species-specific DNA probes. J Clin Microbiol. 1998;36(11):3260–3265. doi:10.1128/JCM.36.11.3260-3265.1998
   Web of Science ®Google Scholar
• Fujita S, Lasker BA, Lott TJ, Reiss E, Morrison CJ. Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. J Clin Microbiol. 1995;33(4):962–967. doi:10.1128/jcm.33.4.962-967.1995
   Web of Science ®Google Scholar
• Michel-Nguyen A, Favel A, Chastin C, Selva M, Regli P. Comparative evaluation of a commercial system for identification of Candida lusitaniae. Eur J Clin Microbiol Infect Dis. 2000;19(5):393–395. doi:10.1007/PL00011231
   Web of Science ®Google Scholar
• Campbell CK, Davey KG, Holmes AD, Szekely A, Warnock DW. Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens. J Clin Microbiol. 1999;37(3):821–823. doi:10.1128/JCM.37.3.821-823.1999
   Web of Science ®Google Scholar
• Arendrup M, Horn T, Frimodt-Møller N. In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection. 2002;30(5):286–291. doi:10.1007/s15010-002-2131-0
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Iqbal N, Cleveland AA, et al. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol. 2012;50(11):3435–3442. doi:10.1128/JCM.01283-12
   PubMed Web of Science ®Google Scholar
• Barchiesi F, Tortorano AM, Di Francesco LF, Cogliati M, Scalise G, Viviani MA. In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp. J Antimicrob Chemother. 1999;43(2):295–299. doi:10.1093/jac/43.2.295
   Web of Science ®Google Scholar
• Favel A, Michel-Nguyen A, Peyron F, et al. Colony morphology switching of Candida lusitaniae and acquisition of multidrug resistance during treatment of a renal infection in a newborn: case report and review of the literature. Diagn Microbiol Infect Dis. 2003;47(1):331–339. doi:10.1016/S0732-8893(03)00094-4
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Andes D, et al. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat. 2011;14(3):164–176. doi:10.1016/j.drup.2011.01.004
   PubMed Web of Science ®Google Scholar
• Abruzzo GK, Flattery AM, Gill CJ, et al. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother. 1997;41(11):2333–2338. doi:10.1128/AAC.41.11.2333
   PubMed Web of Science ®Google Scholar
• Asner SA, Giulieri S, Diezi M, Marchetti O, Sanglard D. Acquired multidrug antifungal resistance in Candida lusitaniae during therapy. Antimicrob Agents Chemother. 2015;59(12):7715–7722. doi:10.1128/AAC.02204-15
   PubMed Web of Science ®Google Scholar
• Dunkel N, Blass J, Rogers PD, Morschhäuser J. Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains. Mol Microbiol. 2008;69(4):827–840. doi:10.1111/j.1365-2958.2008.06309.x
   PubMed Web of Science ®Google Scholar
• Krcmery V Jr, Oravcova E, Spanik S, et al. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. J Antimicrob Chemother. 1998;41(3):373–380. doi:10.1093/jac/41.3.373
   Web of Science ®Google Scholar
• Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis. 2000;30(4):662–678. doi:10.1086/313749
   PubMed Web of Science ®Google Scholar
• Bouchara JP, Zouhair R, Leb S, et al. In-vivo selection of an azole-resistant petite mutant of Candida glabrata. J Med Microbiol. 2000;49(11):977–984. doi:10.1099/0022-1317-49-11-977
   Web of Science ®Google Scholar
• Vargas K, Messer SA, Pfaller M, et al. Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode. J Clin Microbiol. 2000;38(10):3595–3607. doi:10.1128/JCM.38.10.3595-3607.2000
   Web of Science ®Google Scholar
• Odds EC. Switch of phenotype as an escape mechanism of the intruder. Mycoses. 1997;40(Suppl 2):9–12. doi:10.1111/j.1439-0507.1997.tb00556.x
   PubMed Web of Science ®Google Scholar
• Peyron F, Favel A, Calaf R, Michel-Nguyen A, Bonaly R, Coulon J. Sterol and fatty acid composition of Candida lusitaniae clinical isolates. Antimicrob Agents Chemother. 2002;46(2):531–533. doi:10.1128/AAC.46.2.531-533.2002
   Web of Science ®Google Scholar
• Ghannoum MA, Rice LB. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev. 1999;12(4):501–517. doi:10.1128/CMR.12.4.501
   PubMed Web of Science ®Google Scholar
• Kamai Y, Kubota M, Kamai Y, Hosokawa T, Fukuoka T, Filler SG. Contribution of Candida albicans ALS1 to the pathogenesis of experimental oropharyngeal candidiasis. Infect Immun. 2002;70(9):5256–5258. doi:10.1128/IAI.70.9.5256-5258.2002
   Web of Science ®Google Scholar
• Gil-Bona A, Reales-Calderon JA, Parra-Giraldo CM, Martinez-Lopez R, Monteoliva L, Gil C. The cell wall protein Ecm33 of Candida albicans is Involved in chronological life span, morphogenesis, cell wall regeneration, stress tolerance, and host–cell interaction. Front Microbiol. 2016;7:64. doi:10.3389/fmicb.2016.00064
   Web of Science ®Google Scholar
• Kempf M, Apaire-Marchais V, Saulnier P, et al. Disruption of Candida albicans IFF4 gene involves modifications of the cell electrical surface properties. Colloids Surf B: Biointer. 2007;58(2):250–255. doi:10.1016/j.colsurfb.2007.03.017
   PubMed Web of Science ®Google Scholar
• Gomez MJ, Torosantucci A, Arancia S, Maras B, Parisi L, Cassone A. Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans. Infect Immun. 1996;64(7):2577–2584. doi:10.1128/iai.64.7.2577-2584.1996
   Web of Science ®Google Scholar
• Nobile CJ, Mitchell AP. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol. 2005;15(12):1150–1155. doi:10.1016/j.cub.2005.05.047
   PubMed Web of Science ®Google Scholar
• Burt ET, Daly R, Hoganson D, Tsirulnikov Y, Essmann M, Larsen B. Isolation and partial characterization of Hsp90 from Candida albicans. Ann Clin Lab Sci. 2003;33(1):86–93.
   Web of Science ®Google Scholar
• Chen CG, Yang YL, Shih HI, Su CL, Lo HJ. CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1. Antimicrob Agents Chemother. 2004;48(12):4505–4512. doi:10.1128/AAC.48.12.4505-4512.2004
   PubMed Web of Science ®Google Scholar
• Araújo D, Henriques M, Silva S. Portrait of Candida species biofilm regulatory network genes. Trends Microbiol. 2017;25(1):62–75. doi:10.1016/j.tim.2016.09.004
   PubMed Web of Science ®Google Scholar
• Kenno S, Speth C, Rambach G, et al. Candida albicans factor H binding molecule Hgt1p – a low glucose-induced transmembrane protein is trafficked to the cell wall and impairs phagocytosis and killing by human neutrophils. Front Microbiol. 2019;9:3319. doi:10.3389/fmicb.2018.03319
   Web of Science ®Google Scholar
• Swidergall M, Ernst AM, Ernst JF. Candida albicans mucin Msb2 is a broad-range protectant against antimicrobial peptides. Antimicrob Agents Chemother. 2013;57(8):3917–3922. doi:10.1128/AAC.00862-13
   Web of Science ®Google Scholar
• Marcil A, Gadoury C, Ash J, Zhang J, Nantel A, Whiteway M. Analysis of PRA1 and its relationship to Candida albicans- macrophage interactions. Infect Immun. 2008;76(9):4345–4358. doi:10.1128/IAI.00588-07
   Web of Science ®Google Scholar
• Leidich SD, Ibrahim AS, Fu Y, et al. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem. 1998;273(40):26078–26086. doi:10.1074/jbc.273.40.26078
   PubMed Web of Science ®Google Scholar
• Sun JN, Solis NV, Phan QT, et al. Host cell invasion and virulence mediated by Candida albicans Ssa1. PLoS Pathog. 2010;6(11):e1001181. doi:10.1371/journal.ppat.1001181
   PubMed Web of Science ®Google Scholar